177 related articles for article (PubMed ID: 17314999)
1. Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine.
Weycker D; Edelsberg J; Vincze G; Kjeldsen SE; Jamerson K; Khan ZM; Oster G
J Hum Hypertens; 2007 May; 21(5):374-80. PubMed ID: 17314999
[TBL] [Abstract][Full Text] [Related]
2. Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial.
Kjeldsen SE; McInnes GT; Mancia G; Hua TA; Julius S; Weber MA; Coca A; Girerd X; Jamerson K; Larochelle P; Macdonald T; Schmieder RE; Anthony Schork M; Viskoper R; Widimsky J; Zanchetti A
Blood Press; 2008; 17(3):170-7. PubMed ID: 18608200
[TBL] [Abstract][Full Text] [Related]
3. Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.
Kjeldsen SE; Julius S; Mancia G; McInnes GT; Hua T; Weber MA; Coca A; Ekman S; Girerd X; Jamerson K; Larochelle P; MacDonald TM; Schmieder RE; Schork MA; Stolt P; Viskoper R; Widimský J; Zanchetti A;
J Hypertens; 2006 Jul; 24(7):1405-12. PubMed ID: 16794491
[TBL] [Abstract][Full Text] [Related]
4. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
Baser O; Andrews LM; Wang L; Xie L
J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.
Zanchetti A; Julius S; Kjeldsen S; McInnes GT; Hua T; Weber M; Laragh JH; Plat F; Battegay E; Calvo-Vargas C; Cieśliński A; Degaute JP; Holwerda NJ; Kobalava J; Pedersen OL; Rudyatmoko FP; Siamopoulos KC; Störset O
J Hypertens; 2006 Nov; 24(11):2163-8. PubMed ID: 17053536
[TBL] [Abstract][Full Text] [Related]
6. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
Jackson KC; Sheng X; Nelson RE; Keskinaslan A; Brixner DI
Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997
[TBL] [Abstract][Full Text] [Related]
7. Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial.
Aksnes TA; Kjeldsen SE; Rostrup M; Störset O; Hua TA; Julius S
J Hum Hypertens; 2008 Aug; 22(8):520-7. PubMed ID: 18509347
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.
Fogari R; Zoppi A; Mugellini A; Corradi L; Lazzari P; Preti P; Derosa G
J Cardiovasc Pharmacol; 2008 Mar; 51(3):217-22. PubMed ID: 18356684
[TBL] [Abstract][Full Text] [Related]
9. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.
Schmieder RE; Kjeldsen SE; Julius S; McInnes GT; Zanchetti A; Hua TA;
J Hypertens; 2008 Mar; 26(3):403-11. PubMed ID: 18300848
[TBL] [Abstract][Full Text] [Related]
10. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
13. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
[TBL] [Abstract][Full Text] [Related]
14. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
Ferri C; Croce G; Desideri G
Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of amlodipine-valsartan single-pill combinations: hierarchical modeling of blood pressure and total cardiovascular disease risk outcomes (the EXCELLENT study).
Lins R; Aerts A; Coen N; Hermans C; MacDonald K; Brié H; Lee C; Shen YM; Vancayzeele S; Mecum N; Abraham I
Ann Pharmacother; 2011 Jun; 45(6):727-39. PubMed ID: 21666094
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan.
Weycker D; Keskinaslan A; Levy DG; Edelsberg J; Kartashov A; Oster G
Blood Press Suppl; 2008 Dec; 2():5-12. PubMed ID: 19205091
[TBL] [Abstract][Full Text] [Related]
17. Single-pill combination of amlodipine and valsartan in the management of hypertension.
Flack JM; Hilkert R
Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937
[TBL] [Abstract][Full Text] [Related]
18. The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy.
Julius S; Weber MA; Kjeldsen SE; McInnes GT; Zanchetti A; Brunner HR; Laragh J; Schork MA; Hua TA; Amerena J; Balazovjech I; Cassel G; Herczeg B; Koylan N; Magometschnigg D; Majahalme S; Martinez F; Oigman W; Seabra Gomes R; Zhu JR
Hypertension; 2006 Sep; 48(3):385-91. PubMed ID: 16864741
[TBL] [Abstract][Full Text] [Related]
19. The VALUE trial: a commentary.
Sever P
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):99-101. PubMed ID: 15526243
[TBL] [Abstract][Full Text] [Related]
20. [The value of VALUE--a hypertension study which compared valsartan with amlodipine. New data support early, optimal blood pressure control for high-risk patients].
Nilsson PM
Lakartidningen; 2004 Jul; 101(30-31):2426-7. PubMed ID: 15314941
[No Abstract] [Full Text] [Related]
[Next] [New Search]
